Background and Aims Both China and Thailand attach great importance to education and are committed to high educational standards on an international level. Our study is to compare the medical education reforms that have occurred in China and Thailand to further improve the medical education system in China. Methods Through a search of official documents and prior studies, as well as consultation with Thai students studying in China, we gathered data regarding the evolution of the medical education systems in China and Thailand. The aggregate materials are incorporated into the summary and analysis. Results Over 200 journals and literature were analyzed retrospectively. Thailand's medical education reforms encompass Western strategies without neglecting domestic cultural factors and priorities, and a standardized and medical education system has been established. Chinese medical education reform has yielded remarkable results, though further improvements remain necessary. Conclusion Reforms of Thailand's medical education system offer important experiences and lessons for China, that the development of medical education needs to absorb the merits of others and also needs to have its own national characteristics. The key to medical education reform in China lies in the establishment of a system that is dedicated to science, while also serving its primary purpose of training high‐level medical talent that can meet the needs of Chinese society.
Background Obstetric critical illness is an important factor that leads to an increase in maternal mortality. Early warning assessment can effectively reduce maternal and neonatal mortality and morbidity. However, there are multiple early warning systems, and the effect and applicability of each system in China still need to be explored. Objectives To elaborate on the application, effectiveness and challenges of the existing early warning systems for high‐risk obstetric women in China and to provide a reference for clinical practice. Design A scoping review guided by the Arksey and O'Malley framework and reported using the Preferred Reporting Items for Systematic Reviews and Meta‐Analysis for scoping review (PRISMA‐ScR) guidelines. Eligibility criteria We included original studies related to early warning and excluded those that were guidelines, consensus and reviews. The included studies were published in Chinese or English by Chinese scholars as of June 2021. Data sources CNKI, Wanfang, VIP, Cochrane, CINAHL, Embase, PubMed and Web of Science databases were searched systematically, and the reference sections of the included papers were snowballed. Results In total, 598 articles were identified. These articles were further refined using keyword searches and exclusion criteria, and 17 articles met the inclusion criteria. We extracted data related to each study's population, methods and results. Early warning tools, outcome indices, effects and challenges are discussed. Conclusions Although all studies have shown that early warning systems have good application effects, the use of early warning systems in China is still limited, with poor regional management and poor sensitivity for specific obstetric women. Future research needs to develop more targeted early warning tools for high‐risk obstetric women and address the current challenges in clinical applications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.